CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Leerink Swann Cancer Roundtable Conference titled Conquering Cancer with Novel Therapeutics, to be held at The Grand Hyatt in New York, New York on Friday, May 9, 2008. Timothy P. Clackson, Ph.D., senior vice president and chief scientific officer at ARIAD, will provide an overview of the Company and its progress in key programs in a corporate presentation at 10:00 a.m. (ET). Dr. Clackson also will participate in a panel discussion titled, “Novel Targeted Agents for Cancer – What Target and Which Pathway?” at 8:35 a.m. (ET).
